Merck's COVID-19 pill could pose risks during pregnancy: report

While the Food and Drug Administration (FDA) is expected to soon rule on whether to authorize Merck's COVID-19 pill, questions remain regarding its risks in pregnant women. 

Related Keywords

New York ,United States ,Ronald Swanstrom ,Roy Baynes ,Pfizer ,New York Times ,University Of North Carolina At Chapel Hill ,Drug Administration ,North Carolina ,Fox New ,